Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Survival Without Progression × Celecoxib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 18 Carcinoma, Non-Small-Cell Lung 14 Breast Neoplasms 14 Lung Neoplasms 12 Head and Neck Neoplasms 9 Rectal Neoplasms 8 Prostatic Neoplasms 7 Mouth Neoplasms 5 Glioblastoma 5 Esophageal Neoplasms 5 Colonic Neoplasms 5 Central Nervous System Neoplasms 5 Pancreatic Neoplasms 4 Neoplasm Metastasis 4 Gliosarcoma 4 Squamous Cell Carcinoma of Head and Neck 3 Sarcoma 3 Ovarian Neoplasms 3 Oropharyngeal Neoplasms 3 Neuroblastoma 3 Neoplasms 3 Hypopharyngeal Neoplasms 3 Carcinoma 3 Brain Neoplasms 3 Uterine Cervical Dysplasia 2 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Recurrence 2 Precancerous Conditions 2 Nasopharyngeal Neoplasms 2

Interventions

Vinblastine 1 Methotrexate 1 Cyclophosphamide 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01285817 2023-03-13

SFCE METRO 01

Assistance Publique Hopitaux De Marseille

Phase 2 Completed

Survival Without Progression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡